stockrow
Saturday 7 November 2026
Export JYNT’s income statement to Excel — free account
The Joint Corp.
JYNT Healthcare Medical Care Facilities
The Joint Corp.’s revenue for fiscal 2025 (year ended December 2025) was $54.9 million, up 5.24% from fiscal 2024.
- Revenue
- +14.4%
- EPS
- +400.0%
- Free cash flow
- +432.3%
Quarter to June 2026, against a year earlier
6.89
0.48
−6.51%
Follow JYNT
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
45.89 | 0.00 | 0.00 | 451.48 | 125.70 | 28.24 | 70.17 | 770.37 | 0.00 | 0.00 |
Piotroski F-Score |
7 | 7 | 4 | 6 | 5 | 5 | 5 | 7 | 5 | 4 |
P/S ratio |
2.40 | 3.04 | 1.18 | 1.97 | 11.76 | 6.27 | 4.60 | 3.10 | 2.60 | 1.64 |
Altman Z-Score |
2.39 | 1.98 | 1.70 | 2.85 | 10.97 | 5.79 | 3.80 | 2.41 | 0.39 | (2.10) |
P/FCF ratio |
0.00 | 53.68 | 31.52 | 0.00 | 172.09 | 65.38 | 93.05 | 28.34 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
0.99 | 1.12 | 0.43 | (0.20) | 0.97 | 0.75 | (1.87) | (4.84) | (7.05) | (10.80) |
P/Operating CF |
45.55 | 38.40 | 41.03 | 38.54 | 675.51 | 86.00 | 79.18 | 31.91 | 42.72 | (66.81) |
Beneish M-Score |
(2.27) | (3.58) | (4.18) | (2.74) | (2.12) | (2.53) | (0.93) | (3.72) | (3.16) | (3.28) |
P/B ratio |
8.75 | 7.67 | 5.60 | 6.12 | 31.04 | 17.41 | 38.99 | 156.30 | 56.27 | 4.86 |
Price to Tangible BV |
12.17 | 9.65 | 11.20 | 15.15 | 45.86 | 26.97 | 0.00 | 0.00 | 0.00 | 18.32 |
EV/Sales |
2.00 | 2.58 | 1.05 | 1.91 | 11.56 | 5.99 | 4.47 | 2.89 | 2.47 | 1.48 |
EV/EBITDA |
137.04 | 47.51 | 13.89 | 25.82 | 92.04 | 42.76 | 40.79 | 62.32 | 0.00 | 0.00 |
EV/Operating CF |
59.66 | 14.30 | 8.42 | 23.51 | 66.80 | 31.46 | 28.82 | 19.42 | (831.05) | (2.81) |
EV/FCF |
(22.20) | 45.56 | 28.07 | (65.11) | 169.20 | 62.54 | 90.43 | 26.38 | (72.59) | (2.39) |
Quick Ratio |
0.83 | 0.58 | 0.65 | 0.62 | 1.10 | 1.24 | 0.83 | 0.94 | 1.01 | 0.75 |
Current Ratio |
1.59 | 1.52 | 1.32 | 0.76 | 1.25 | 1.37 | 0.98 | 1.10 | 1.24 | 0.97 |
Net Debt/EBITDA |
(30.37) | (9.18) | (1.93) | (1.14) | (1.77) | (1.94) | (1.18) | (4.56) | 2.45 | 0.24 |
Debt/Assets |
0.00% | 0.00% | 2.29% | 2.21% | 2.40% | 7.38% | 5.43% | 4.70% | 5.97% | 1.94% |
Debt/Equity |
0.00 | 0.00 | 0.08 | 0.06 | 0.07 | 0.23 | 0.41 | 1.51 | 0.95 | 0.05 |
Asset Turnover |
0.76 | 0.61 | 0.52 | 1.12 | 1.05 | 1.07 | 1.44 | 1.75 | 1.40 | 0.81 |
Operating CF/Net income |
0.63 | (1.62) | (1.51) | 13.10 | 1.83 | 0.85 | 2.26 | 37.17 | 0.02 | 0.71 |
Capex/Depreciation |
(0.88) | (0.25) | (0.58) | (0.89) | (1.78) | (1.53) | (2.19) | (0.71) | (0.22) | (0.74) |
| 16.26% | (25.51%) | (34.00%) | 1.99% | 29.42% | 98.09% | 103.09% | 15.60% | (84.97%) | (109.94%) | |
| 4.03% | (6.81%) | (10.79%) | 0.69% | 9.89% | 24.03% | 9.90% | 0.70% | (19.34%) | (60.19%) | |
ROIC |
0.00% | 0.00% | 2.63% | 2.15% | 30.67% | 66.43% | 0.00% | 0.00% | 0.00% | (239.74%) |
Return on Tangible Assets |
12.96% | (20.17%) | (66.95%) | 5.28% | 38.13% | 84.21% | 52.60% | 3.13% | (67.41%) | (332.94%) |
Average Days of Receivables |
18.95 | 18.10 | 20.05 | 14.10 | 16.88 | 12.83 | 19.93 | 8.03 | 16.67 | 18.92 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
78.21% | 78.79% | 74.34% | 83.15% | 77.83% | 74.98% | 77.31% | 81.99% | 90.66% | 129.15% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.21 | 0.11 | 0.11 | 0.17 | 0.21 | 0.25 | 0.30 |
Share Based Compensation of Revenue |
2.36% | 3.22% | 3.70% | 1.26% | 1.32% | 1.51% | 1.49% | 1.71% | 2.39% | 5.47% |
Graham Net Nets |
0.05 | 0.08 | (0.13) | (0.22) | (0.03) | (0.05) | (0.11) | (0.10) | (0.16) | (0.13) |
Graham Number |
2.06 | 0.00 | 0.00 | 1.24 | 4.99 | 5.62 | 1.46 | 0.11 | 0.00 | 0.00 |
Earnings Yield |
2.18% | (3.67%) | (7.00%) | 0.22% | 0.80% | 3.54% | 1.43% | 0.13% | (5.31%) | (45.28%) |
Free Cash Flow Yield |
(3.74%) | 1.86% | 3.17% | (1.49%) | 0.58% | 1.53% | 1.07% | 3.53% | (1.31%) | (37.86%) |
Revenue per Share |
3.63 | 3.50 | 3.20 | 6.99 | 5.59 | 4.19 | 3.51 | 2.68 | 1.88 | 1.62 |
Operating CF per Share |
0.12 | 0.63 | 1.00 | 0.57 | 0.97 | 0.80 | 0.54 | 0.40 | (0.01) | (0.85) |
Capex per Share |
(0.10) | (0.08) | (0.34) | (0.41) | (0.49) | (0.30) | (0.30) | (0.08) | (0.03) | (0.15) |
Free Cash Flow per Share |
0.02 | 0.55 | 0.66 | 0.16 | 0.48 | 0.50 | 0.24 | 0.32 | (0.04) | (1.00) |
Cash per Share |
1.61 | 1.74 | 1.31 | 0.73 | 1.39 | 1.49 | 0.63 | 0.65 | 0.33 | 0.26 |
Shareholders Equity per Share |
1.00 | 1.39 | 1.69 | 2.25 | 2.12 | 1.51 | 0.41 | 0.05 | 0.09 | 0.55 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.00 | 1.39 | 1.69 | 2.25 | 2.12 | 1.51 | 0.41 | 0.05 | 0.09 | 0.55 |
Free Cash Flow |
0.33 | 8.23 | 9.68 | 2.31 | 6.85 | 6.99 | 3.36 | 4.34 | (0.52) | (12.74) |
Working Capital |
19.27 | 25.54 | 10.76 | (5.60) | 5.45 | 6.89 | (0.26) | 1.03 | 1.29 | (0.17) |
Capital Expenditures |
(1.50) | (1.19) | (5.00) | (5.90) | (6.99) | (4.20) | (4.17) | (1.11) | (0.45) | (1.89) |
Net Current Asset Value |
6.20 | 12.10 | (18.10) | (43.29) | (29.86) | (19.41) | (24.68) | (11.40) | (10.61) | (4.43) |
EV/EBIT |
0.00 | 0.00 | 388.28 | 233.06 | 150.97 | 64.05 | 63.48 | 742.43 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.02 | 0.11 | 0.06 | 0.09 | 0.07 | 0.09 | 0.03 | 0.02 | 0.09 |
Price to Operating Income |
0.00 | 0.00 | 436.07 | 240.89 | 153.55 | 66.96 | 65.32 | 797.52 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.54 | 1.47 | 2.26 | 0.38 | 0.27 | 0.31 | 0.29 | 0.43 | 0.53 | 0.54 |
Cash ROIC |
0.85% | 17.63% | 21.05% | 5.11% | 13.10% | 14.93% | 20.06% | 40.64% | (7.96%) | (120.18%) |
Accounts Receivable Turnover |
20.20 | 20.19 | 14.47 | 26.60 | 27.76 | 24.93 | 28.07 | 37.70 | 22.63 | 21.86 |
Accounts Payable Turnover |
6.72 | 7.67 | 4.97 | 3.93 | 4.69 | 4.22 | 4.01 | 3.71 | 3.04 | 1.93 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
51.66 | 55.49 | 43.66 | 118.07 | 81.22 | 87.59 | 100.06 | 106.13 | 120.98 | 130.98 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
2.72 | 2.58 | 3.25 | 3.81 | 2.88 | 2.35 | 1.73 | 0.97 | 1.10 | 0.94 |
Average Payables |
1.67 | 1.50 | 2.11 | 2.34 | 1.63 | 1.54 | 1.39 | 1.16 | 1.06 | 1.53 |
Average Assets |
72.06 | 85.18 | 90.35 | 90.28 | 76.47 | 54.79 | 33.57 | 20.93 | 17.75 | 25.21 |
Average Common Equity |
17.88 | 22.73 | 28.68 | 31.45 | 25.72 | 13.42 | 3.22 | 0.94 | 4.04 | 13.80 |
Columns are period end dates · fundamentals updated 25 Oct 2026